Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP799774.RAfnVthVfMYucQr5a0elr5zXi5Nf1kCKBjOotTaD4_yzw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP799774.RAfnVthVfMYucQr5a0elr5zXi5Nf1kCKBjOotTaD4_yzw130_assertion type Assertion NP799774.RAfnVthVfMYucQr5a0elr5zXi5Nf1kCKBjOotTaD4_yzw130_head.
- NP799774.RAfnVthVfMYucQr5a0elr5zXi5Nf1kCKBjOotTaD4_yzw130_assertion description "[p53 is usually inactivated by point mutations during tumorigenesis, whereas the expression levels and p63 and p73 are modulated to give tumor cells a selective advantage.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP799774.RAfnVthVfMYucQr5a0elr5zXi5Nf1kCKBjOotTaD4_yzw130_provenance.
- NP799774.RAfnVthVfMYucQr5a0elr5zXi5Nf1kCKBjOotTaD4_yzw130_assertion evidence source_evidence_literature NP799774.RAfnVthVfMYucQr5a0elr5zXi5Nf1kCKBjOotTaD4_yzw130_provenance.
- NP799774.RAfnVthVfMYucQr5a0elr5zXi5Nf1kCKBjOotTaD4_yzw130_assertion SIO_000772 20298673 NP799774.RAfnVthVfMYucQr5a0elr5zXi5Nf1kCKBjOotTaD4_yzw130_provenance.
- NP799774.RAfnVthVfMYucQr5a0elr5zXi5Nf1kCKBjOotTaD4_yzw130_assertion wasDerivedFrom befree-20150227 NP799774.RAfnVthVfMYucQr5a0elr5zXi5Nf1kCKBjOotTaD4_yzw130_provenance.
- NP799774.RAfnVthVfMYucQr5a0elr5zXi5Nf1kCKBjOotTaD4_yzw130_assertion wasGeneratedBy ECO_0000203 NP799774.RAfnVthVfMYucQr5a0elr5zXi5Nf1kCKBjOotTaD4_yzw130_provenance.